Renaud de Crevoisier is an expert in Radiotherapy at Centre Eugène Marquis (France). As of October 2026, ScienceLeadR ranks Renaud de Crevoisier in the top 1% of experts worldwide for Prostatic Diseases, Urogenital Neoplasms and Genital Diseases, Male. Renaud de Crevoisier has authored 294 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 1 of them ongoing. SLR score: 1,099 (community average: 125). How the SLR is computed.

LeadR Profile

Renaud de Crevoisier Centre Eugène Marquis France
1 099 ScienceLeadR Reputation 1099
Network Map

Radiotherapy

Subspecialties: Cardiology - Urology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026

Source: PubMed

Centre Eugène Marquis

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 294

Citations

Citations: 7 546 1st author: 30 Last author: 80 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Variability and Main Determinants of Planning Target Volume During Cardiac Stereotactic Radioablation for Refractory Ventricular Arrhythmias: A Systematic Review and Pooled Analysis.
PMID 42541480 — radiotherapy, electrophysiology, arrhythmias, cardiac, therapeutics
J Cardiovasc Electrophysiol20260
Magnetic resonance imaging-guided radiotherapy for prostate cancer: A systematic review of the literature.
PMID 42229011 — radiotherapy, radiotherapy, image-guided, neoplasms, prostate, magnetic resonance imaging, prostatic neoplasms, therapeutics, salvage therapy
Cancer Radiother20260
Iatrogenic Ventricular Septal Defect: A Severe Structural Complication 2 Years After Stereotactic Arrhythmia Radioablation.
PMID 42101394 — radiotherapy, tachycardia, ventricular, arrhythmias, cardiac, cardiovascular diseases, heart septal defects, ventricular
JACC Clin Electrophysiol20260
Image-guided radiotherapy: From prepositionning to treatment delivery.
PMID 41875763 — radiotherapy, radiotherapy, image-guided, therapeutics
Cancer Radiother20260
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study.
PMID 41864432 — retrospective studies, neoplasms, prostate, re-irradiation, prostatic neoplasms, therapeutics
Int J Radiat Oncol Biol Phys20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

N/A 4
Phase 3 3
Phase 1/Phase 2 1
Phase 2 1

By status:

Completed 3
Recruiting 2
Unknown 2
Active not recruiting 1
Terminated 1

By type:

Interventional 8
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 2
multicentricup10 5

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High Risk Prostate Cancer
NCT07189598 — radiotherapy, clinical protocols, lymph nodes, radiosurgery, neoplasms, prostate, prescriptions, lymph, prostatic neoplasms, seminal vesicles
N/ARecruiting2026

LeadR Networks

Main global connection map